Our work on the selective in vivo delivery and efficacy of pHLIP-MMAF conjugates just got published in Molecular Pharmaceutics: http://pubs.acs.org/doi/abs/10.1021/acs.molpharmaceut.6b00847
Congratulations to Dr. Burns, who successfully defended her Ph.D. Thesis. She is the first PhD student to graduate from the Thévenin Lab. We are all very proud of her. She will continue her research endeavor at the US Naval Research Laboratory (Center for Biomolecular Science & Engineering) in Washington, D.C.
“Down-Regulation of PAR1 Activity with a pHLIP-based Allosteric Antagonist Induces Cancer Cell Death”
“Inhibition of Cancer Cell Proliferation and Breast Tumor Targeting of pHLIP-monomethyl Auristatin E Conjugates”